Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets
Open accessThe DOI matches its Crossref record; 235 of the 237 references it cites were found in a registry or an index.
Abstract
NADPH oxidases are a family of enzymes that generate reactive oxygen species (ROS). The NOX1 (NADPH oxidase 1) and NOX2 oxidases are the major sources of ROS in the artery wall in conditions such as hypertension, hypercholesterolaemia, diabetes and ageing, and so they are important contributors to the oxidative stress, endothelial dysfunction and vascular inflammation that underlies arterial remodelling and atherogenesis. In this Review, we advance the concept that compared to the use of conventional antioxidants, inhibiting NOX1 and NOX2 oxidases is a superior approach for combating oxidative stress. We briefly describe some common and emerging putative NADPH oxidase inhibitors. In addition, we highlight the crucial role of the NADPH oxidase regulatory subunit, p47phox, in the activity of vascular NOX1 and NOX2 oxidases, and suggest how a better understanding of its specific molecular interactions may enable the development of novel isoform-selective drugs to prevent or treat cardiovascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The current knowledge about NOX enzymes in the cardiovascular system indicates that NOX2 is usually the main player in the development of pathological conditions and increased NOX2 activity is linked to vascular disease (142, 252, 478).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [252]
The cited source says what the claim attributes to it.
In the citing paper
“In the human vasculature, the most relevant isoforms appear to be NOX1, NOX2, NOX4, and NOX5 (252, 253, 555).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [252]
In the citing paper
“NADPH oxidase, a multiunit enzyme particularly enriched in cerebral blood vessels (Miller et al., 2005), has emerges as an important source in vascular oxidative stress in aging, hypertension, hyperlipidemia and diabetes (Faraci, 2011), and inhibition or genetic inactivation of this enzyme has been shown to ameliorate the vascular dysfunction (Drummond et al., 2011).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Drummond et al., 2011
In the citing paper
“NOXs are multiprotein enzyme complexes that catalyze the electron transfer to molecular oxygen to form ROS, more commonly superoxide, but also hydrogen peroxide (79, 252, 383, 546, 912).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [252]
In the citing paper
“The current knowledge about NOX enzymes in the cardiovascular system indicates that NOX2 is usually the main player in the development of pathological conditions and increased NOX2 activity is linked to vascular disease (142, 252, 478).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [252]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989 · cited 1×
“As vascular NADPH oxidases, especially NOX2 oxidase, are similar in structure to the phagocytic NADPH oxidase (see below and Ref”
BackgroundNOX enzymes and the biology of reactive oxygen
Lambeth, J. D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1312 · Cited by 3,125 · cited 1×
“NOX2 oxidase in phagocytic cells was the first member of the NADPH oxidase family to be identifie”
BackgroundAngiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.
Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., & Alexander, R. W. (1994) · Circulation Research · doi:10.1161/01.res.74.6.1141 · Cited by 2,735
Self-citationRole of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624 · cited 1×
“Oxidative stress not only causes direct and irreversible oxidative damage to macromolecules but also disrupts key redox-dependent signalling processes in the arterial wal”
BackgroundSuperoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
Gryglewski, R. J., Palmer, R. M. J., & Moncada, S. (1986) · Nature · doi:10.1038/320454a0 · Cited by 2,400 · cited 1×
“This nullifies the anti-inflammatory and vasodilator functions of NO, and promotes the formation of peroxynitrit”
BackgroundPeroxynitrite: biochemistry, pathophysiology and development of therapeutics
Szabó, C., Ischiropoulos, H., & Radi, R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2222 · Cited by 2,134 · cited 1×
“Peroxynitrite is a powerful oxidant in its own right, and may thus contribute to oxidative stress through oxidation of small-molecule antioxidants such as glutathione, cysteine and tetrahydro—biopteri”
BackgroundSegal, A. W. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115653 · Cited by 1,789 · cited 1×
“NOX2 oxidase-expressing leukocytes classically comprise cells of the innate immune system — that is, neutrophils, monocytes and macrophage”
BackgroundRole of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction
Guzik, T. J., Hoch, N. E., Brown, K. A., McCann, L. A., Rahman, A., Dikalov, S., Goronzy, J., Weyand, C., & Harrison, D. G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070657 · Cited by 1,736 · cited 1×
“NOX2 oxidase activity in circulating T lymphocytes is increased in experimental hypertensio”
BackgroundChronic Granulomatous Disease: Report on a National Registry of 368 Patients
Winkelstein, J. A., Marino, M. C., Johnston, R. B., Boyle, J., Curnutte, J., Gallin, J. I., Malech, H. L., Holland, S. M., Ochs, H., Quie, P., et al. (2000) · Medicine · doi:10.1097/00005792-200005000-00003 · Cited by 1,728
Immune and Inflammatory Mechanisms of Atherosclerosis
Galkina, E., & Ley, K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132620 · Cited by 1,437
Research works printed but not linked: 1
- Takac, I. et al. The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. J. Biol. Chem. 286, 13304–13313 (2011). · DOI · Paper page
Cited by
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
“Although NAD(P)H oxidase as a potential pathogenic mediator of hyperglycemia induced ROS production, there are some major challenges to be overcome when targeting this pathway including redundancy among Nox isoforms (160) and the capacity of pharmacological agents not to interfere with intracellular O2 generation for…”
BackgroundCommensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Iida, N., Dzutsev, A., Stewart, C. A., Smith, L., Bouladoux, N., Weingarten, R. A., Molina, D. A., Salcedo, R., Back, T., Cramer, S., et al. (2013) · Science · doi:10.1126/science.1240527 · Cited by 2,251
The Pathobiology of Vascular Dementia
Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857
“…(Miller et al., 2005), has emerges as an important source in vascular oxidative stress in aging, hypertension, hyperlipidemia and diabetes (Faraci et al., 2011), and inhibition or genetic inactivation of this enzyme has been shown to ameliorate the vascular dysfunction (Drummond et al., 2011).”
Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis
Förstermann, U., Xia, N., & Li, H. (2017) · Circulation Research · doi:10.1161/circresaha.116.309326 · Cited by 1,519
Oxidative Stress in Atherosclerosis
Kattoor, A. J., Pothineni, N. V. K., Palagiri, D., & Mehta, J. L. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0678-6 · Cited by 1,266
Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus
Tangvarasittichai, S. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.456 · Cited by 1,213
NADPH oxidases: An overview from structure to innate immunity-associated pathologies
Panday, A., Sahoo, M. K., Osorio, D., & Batra, S. (2015) · Cellular & Molecular Immunology · doi:10.1038/cmi.2014.89 · Cited by 944
Free radicals and antioxidants: updating a personal view
Halliwell, B. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2012.00476.x · Cited by 912
Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans
Marrocco, I., Altieri, F., & Peluso, I. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/6501046 · Cited by 855
“Theestablishedrole indiseases ofXO[318]andNOX[319, 320] suggested their pharmacological inhibition in theprevention and treatment of pathologies related to oxidative stress.”
BackgroundEndothelial dysfunction — A major mediator of diabetic vascular disease
Sena, C. M., Pereira, A. M., & Seiça, R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.006 · Cited by 797
“Substances able to inhibit NADPH oxidases and prevent superoxide production may be useful for treatment of endothelial dysfunction [230].”
BackgroundBiochemistry, Physiology, and Pathophysiology of NADPH Oxidases in the Cardiovascular System
Lassègue, B., San Martín, A., & Griendling, K. K. (2012) · Circulation Research · doi:10.1161/circresaha.111.243972 · Cited by 767
Self-citationThe role of oxidative stress during inflammatory processes
Lugrin, J., Rosenblatt-Velin, N., Parapanov, R., & Liaudet, L. (2014) · Biological Chemistry · doi:10.1515/hsz-2013-0241 · Cited by 737
“This process has been particularly well described in the context of inflammatory cardiovascular pathologies, most significantly atherosclerosis, as reviewed recently (Forstermann and Li, 2011; Alkaitis and Crabtree, 2012).”
BackgroundUpregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
Lee, H.-M., Kim, J.-J., Kim, H. J., Shong, M., Ku, B. J., & Jo, E.-K. (2013) · Diabetes · doi:10.2337/db12-0420 · Cited by 734
“A number of studies also have indicated that an altered redox potential and oxidative stress are highly associated with risk factors for type 2 diabetes and its complications (33,34).”
BackgroundOxidative stress in angiogenesis and vascular disease
Kim, Y.-W., & Byzova, T. V. (2014) · Blood · doi:10.1182/blood-2013-09-512749 · Cited by 701
“11 source of ROS in vasculature.(108,109) However, the studies using such inhibitors in vivo animal models(15,16) are limited.”
BackgroundVascular oxidative stress, nitric oxide and atherosclerosis
Li, H., Horke, S., & Förstermann, U. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.09.001 · Cited by 656
Intermittent Hypoxemia and OSA
Dewan, N. A., Nieto, F. J., & Somers, V. K. (2015) · Chest · doi:10.1378/chest.14-0500 · Cited by 641
Impact of Oxidative Stress on the Heart and Vasculature
Münzel, T., Camici, G. G., Maack, C., Bonetti, N. R., Fuster, V., & Kovacic, J. C. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.05.035 · Cited by 619
“They produce O2 from molecular oxygen by using NADPH as an electron donor and are found in various vascular cell types, including ECs (NOX-2 and -4), SMCs (NOX-1 and -4), and fibroblasts (NOX-2 and -4) (62,63).”
Roles of Inflammation, Oxidative Stress, and Vascular Dysfunction in Hypertension
Dinh, Q. N., Drummond, G. R., Sobey, C. G., & Chrissobolis, S. (2014) · BioMed Research International · doi:10.1155/2014/406960 · Cited by 598
“Nicotinamide adenine dinucleotide phosphate-oxidase (NADPH) oxidase is amajor source of ROS in immune cells and also in the vasculature [78].”
BackgroundSelf-citationStrategies to increase nitric oxide signalling in cardiovascular disease
Lundberg, J. O., Gladwin, M. T., & Weitzberg, E. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4623 · Cited by 576
Antioxidant effects of resveratrol in the cardiovascular system
Xia, N., Daiber, A., Förstermann, U., & Li, H. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13492 · Cited by 574
“NADPH oxidases are multi-subunit enzyme complexes consisting of two membrane-bound subunits (NOX and p22phox) and several cytosolic regulatory subunits (Bedard and Krause, 2007; Drummond et al., 2011; Wingler et al., 2011).”
BackgroundROS-triggered endothelial cell death mechanisms: Focus on pyroptosis, parthanatos, and ferroptosis
Zheng, D., Liu, J., Piao, H., Zhu, Z., Wei, R., & Liu, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1039241 · Cited by 566
“EC injury in the early stages of vascular disease has been reported to be mediated by excess NOX2-derived superoxide (31).”
BackgroundMCOLN1 is a ROS sensor in lysosomes that regulates autophagy
Zhang, X., Cheng, X., Yu, L., Yang, J., Calvo, R., Patnaik, S., Hu, X., Gao, Q., Yang, M., Lawas, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms12109 · Cited by 558
Huynh, K., Bernardo, B. C., McMullen, J. R., & Ritchie, R. H. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.01.003 · Cited by 553
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541
NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets
Zhang, Y., Murugesan, P., Huang, K., & Cai, H. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0260-8 · Cited by 534
Evolution of nadph oxidase inhibitors: Selectivity and mechanisms for target engagement
Altenhöfer, S., Radermacher, K. A., Kleikers, P. W. M., Wingler, K., & Schmidt, H. H. H. W. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5814 · Cited by 521
“However, for a long time, a validated physiological function could only be found for NOX2 and DUOX2 based on mutations in humans or mice leaving a dysfunctional protein and therefore leading to chronic granulomatous disease (CGD) or severe hypothyroidism, respectively (47, 80, 113).”
BackgroundOxidative stress and diabetes: antioxidative strategies
Zhang, P., Li, T., Wu, X., Nice, E. C., Huang, C., & Zhang, Y. (2020) · Frontiers of Medicine · doi:10.1007/s11684-019-0729-1 · Cited by 513
Redox Signaling in Cardiac Physiology and Pathology
Burgoyne, J. R., Mongue-Din, H., Eaton, P., & Shah, A. M. (2012) · Circulation Research · doi:10.1161/circresaha.111.255216 · Cited by 482
“The development of specific Nox inhibitors is currently an area of intense activity.(149)”
BackgroundOxidative Stress-Induced Endothelial Dysfunction in Cardiovascular Diseases
Shaito, A., Aramouni, K., Assaf, R., Parenti, A., Orekhov, A., Yazbi, A. E., Pintus, G., & Eid, A. H. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2703105 · Cited by 418
Zhenyukh, O., Civantos, E., Ruiz-Ortega, M., Sánchez, M. S., Vázquez, C., Peiró, C., Egido, J., & Mas, S. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.009 · Cited by 402
Oxidative Stress-Mediated Atherosclerosis: Mechanisms and Therapies
Yang, X., Li, Y., Li, Y., Ren, X., Zhang, X., Hu, D., Gao, Y., Xing, Y., & Shang, H. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00600 · Cited by 404
“These oxidases, composing of two membrane-combined subunits and several cytoplasmic modulatory subunits, are multisubunit enzyme compoundes which produce superoxide from themolecular oxygen employing NADPH served as electron donor (Bedard and Krause, 2007; Cave, 2009; Drummond et al., 2011).”
BackgroundMitochondria: Central Organelles for Melatonin′s Antioxidant and Anti-Aging Actions
Reiter, R., Tan, D., Rosales-Corral, S., Galano, A., Zhou, X., & Xu, B. (2018) · Molecules · doi:10.3390/molecules23020509 · Cited by 393
“The production of the superoxide anion radical (O2•−) and hydrogen peroxide (H2O2) are carefully regulated intracellularly [8,9].”
BackgroundInfluentialMetabolic Effects of Dietary Nitrate in Health and Disease
Lundberg, J. O., Carlström, M., & Weitzberg, E. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.06.007 · Cited by 374
Hypertension: A Harbinger of Stroke and Dementia
Faraco, G., & Iadecola, C. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01063 · Cited by 367
“Treatments targeting oxidative stress have long been considered to treat HTN and related complications,(68) but it has been difficult to develop agents that cross the BBB and effectively reduce oxidative stress in brain.(69) Similarly, epidemiological studies have not shown a beneficial impact of dietary antioxidants…”
The role of mitochondrial ROS in the aging brain
Stefanatos, R., & Sanz, A. (2018) · FEBS Letters · doi:10.1002/1873-3468.12902 · Cited by 358
“In fact, they are the only family of enzymes whose specific function is ROS production (either superoxide or hydrogen peroxide) [24].”
BackgroundReactive oxygen species: key regulators in vascular health and diseases
Chen, Q., Wang, Q., Zhu, J., Xiao, Q., & Zhang, L. (2018) · British Journal of Pharmacology · doi:10.1111/bph.13828 · Cited by 338
“ECs prodominantly express NOX1, NOX2, NOX4 and NOX5; VSMCs mainly express NOX1, NOX4 and NOX5; and adventitial cells express NOX2 and NOX4 (Drummond et al., 2011a; Lassegue et al., 2012).”
BackgroundInfluentialOxidative stress in vascular disease and its pharmacological prevention
Li, H., Horke, S., & Förstermann, U. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.03.007 · Cited by 321
Oxidative Stress and Human Hypertension: Vascular Mechanisms, Biomarkers, and Novel Therapies
Montezano, A. C., Dulak-Lis, M., Tsiropoulou, S., Harvey, A., Briones, A. M., & Touyz, R. M. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.02.008 · Cited by 323
Immune and inflammatory mechanisms in hypertension
Guzik, T. J., Nosalski, R., Maffia, P., & Drummond, G. R. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00964-1 · Cited by 315
“181).”
Self-citationEndothelial NADPH oxidases: which NOX to target in vascular disease?
Drummond, G. R., & Sobey, C. G. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.06.012 · Cited by 315
Self-citationUnuofin, J. O., & Lebelo, S. L. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1356893 · Cited by 308
“Intracellular stimuli that generate reactive species (RS) are induced by nicotinamide adenine dinucleotide phosphate (NADPH) oxidase [15], nitric oxide synthase (NOS) [12, 16], and mitochondrial electron transfer [17].”
BackgroundRedox regulation of protein kinases
Corcoran, A., & Cotter, T. G. (2013) · The FEBS Journal · doi:10.1111/febs.12224 · Cited by 306
Aiding and abetting roles of NOX oxidases in cellular transformation
Block, K., & Gorin, Y. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3339 · Cited by 297
Moon, J.-S., Nakahira, K., Chung, K.-P., DeNicola, G. M., Koo, M. J., Pabón, M. A., Rooney, K. T., Yoon, J.-H., Ryter, S. W., Stout-Delgado, H., et al. (2016) · Nature Medicine · doi:10.1038/nm.4153 · Cited by 291
RetractedUncoupling of endothelial NO synthase in atherosclerosis and vascular disease
Li, H., & Förstermann, U. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.01.006 · Cited by 285
Cadmium-Induced Kidney Injury: Oxidative Damage as a Unifying Mechanism
Yan, L.-J., & Allen, D. C. (2021) · Biomolecules · doi:10.3390/biom11111575 · Cited by 277
“For structures and components of other NXO isoforms, please refer reference [103].”
BackgroundInfluentialMontezano, A. C., & Touyz, R. M. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5302 · Cited by 270
“The Noxs have been extensively reviewed (7, 16, 53, 82, 113, 160), and only an overview of recent developments is discussed here, focusing on the most recently characterized isoform, Nox5.”
Oxidative Stress: A Unifying Paradigm in Hypertension
Touyz, R. M., Rios, F. J., Alves-Lopes, R., Neves, K. B., Camargo, L. L., & Montezano, A. C. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.02.081 · Cited by 266
Oxidative stress and the role of redox signalling in chronic kidney disease
Kishi, S., Nagasu, H., Kidokoro, K., & Kashihara, N. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00775-0 · Cited by 267
Kozel, B. A., Barak, B., Kim, C. A., Mervis, C. B., Osborne, L. R., Porter, M., & Pober, B. R. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00276-z · Cited by 245
The Role of Reactive Oxygen Species (ROS) in the Formation of Extracellular Traps (ETs) in Humans
Stoiber, W., Obermayer, A., Steinbacher, P., & Krautgartner, W.-D. (2015) · Biomolecules · doi:10.3390/biom5020702 · Cited by 249
“Phagocytes have long been known to express large amounts of NADPH oxidase residing in the plasma membrane and in phagosome membranes (Figure 2), but intermediate or low amounts of the enzyme occur in most—if not in all—mammalian cell types and tissues [40,61,62].”
BackgroundVascular Oxidative Stress: Impact and Therapeutic Approaches
Sena, C. M., Leandro, A., Azul, L., Seiça, R., & Perry, G. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01668 · Cited by 246
Regulation of platelet activation and thrombus formation by reactive oxygen species
Qiao, J., Arthur, J. F., Gardiner, E. E., Andrews, R. K., Zeng, L., & Xu, K. (2018) · Redox Biology · doi:10.1016/j.redox.2017.08.021 · Cited by 243
Radiation-induced skin reactions: mechanism and treatment
Wei, J., Meng, L., Hou, X., Qu, C., Wang, B., Xin, Y., & Jiang, X. (2018) · Cancer Management and Research · doi:10.2147/cmar.s188655 · Cited by 240
“36 These enzymes are highly stable and continuously produce ROS following exposure.”
The enigmatic reaction of flavins with oxygen
Chaiyen, P., Fraaije, M. W., & Mattevi, A. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.06.005 · Cited by 236
“Flavoenzyme oxidases are also among the most active generators of ROS, the prime examples of this being the NADPH oxidases [3], mitochondrial Complex I [4], and the monoamine oxidases [5].”
BackgroundZhang, J., Malik, A., Choi, H. B., Ko, R. W. Y., Dissing-Olesen, L., & MacVicar, B. A. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.043 · Cited by 234
“…oxidative stress have shown promising results in clinical studies (Barnham et al., 2004), suggesting that targeting the source of the oxidative stress signals such as NADPH oxidase may be useful in alleviating some of the deterioration in neurodegeneration (Drummond et al., 2011; Gao et al., 2012).”
Montezano, A. C., & Touyz, R. M. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.01.017 · Cited by 231
Cellular and Oxidative Mechanisms Associated with Interleukin-6 Signaling in the Vasculature
Didion, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122563 · Cited by 228
Targeting NADPH oxidases in vascular pharmacology
Schramm, A., Matusik, P., Osmenda, G., & Guzik, T. J. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.02.012 · Cited by 228
“Many studies in experimental models and clinical reports showa link between overproduction of ROS in the vessel wall and the development of atherosclerosis, heart failure, hypertension and plaque instability (Bauersachs and Widder, 2008; Drummond et al., 2011; Guzik and Harrison, 2006).”
Inducible nitric oxide synthase: Good or bad?
Lind, M., Hayes, A., Caprnda, M., Petrovic, D., Rodrigo, L., Kruzliak, P., & Zulli, A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.06.036 · Cited by 229
Role of NADPH Oxidases in Liver Fibrosis
Paik, Y.-H., Kim, J., Aoyama, T., De Minicis, S., Bataller, R., & Brenner, D. A. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5619 · Cited by 219
“Detailed information of these NOX inhibitors has been provided in comprehensive review articles (46, 65, 96).”
BackgroundBiocompatibility of implantable materials: An oxidative stress viewpoint
Mouthuy, P.-A., Snelling, S. J. B., Dakin, S. G., Milković, L., Gašparović, A. Č., Carr, A. J., & Žarković, N. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.09.010 · Cited by 219
“Some authors have suggested that the inhibition of NADPH oxidases (NOX family) is a better approach for combating oxidative stress compared to using conventional antioxidants [156].”
BackgroundTahrir, F. G., Langford, D., Amini, S., Mohseni Ahooyi, T., & Khalili, K. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27597 · Cited by 215
An Activatable NIR‐II Nanoprobe for In Vivo Early Real‐Time Diagnosis of Traumatic Brain Injury
Li, C., Li, W., Liu, H., Zhang, Y., Chen, G., Li, Z., & Wang, Q. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201911803 · Cited by 213
IL‐1β and IL‐18: inflammatory markers or mediators of hypertension?
Krishnan, S. M., Sobey, C. G., Latz, E., Mansell, A., & Drummond, G. R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12876 · Cited by 215
Self-citationOxidative stress in atrial fibrillation: An emerging role of NADPH oxidase
Youn, J.-Y., Zhang, J., Zhang, Y., Chen, H., Liu, D., Ping, P., Weiss, J. N., & Cai, H. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.04.019 · Cited by 214
“NOX isoforms [NOX1–5 or dual oxidase 1–2 (Duox)] recruit separate regulatory subunits for enzymatic assembly and activation [33].”
BackgroundNADPH oxidases: novel therapeutic targets for neurodegenerative diseases
Gao, H.-M., Zhou, H., & Hong, J.-S. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.03.008 · Cited by 213
“DPI has been widely used as a nonspecific NOX2 inhibitor because it shows more potent inhibition of NOX2 than of other flavin-containing enzymes, such as nitric oxide synthases, NADH dehydrogenase, xanthine oxidase, cytochrome p450 oxidoreductase, and NADH-ubiquinone oxidoreductase [3].”
BackgroundMethodRadiation-Induced Normal Tissue Damage: Oxidative Stress and Epigenetic Mechanisms
Wei, J., Wang, B., Wang, H., Meng, L., Zhao, Q., Li, X., Xin, Y., & Jiang, X. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3010342 · Cited by 209
“They participate in the process of respiratory chain rupture after radiation [15].”
BackgroundEndothelial Dysfunction in Diabetic Retinopathy
Gui, F., You, Z., Fu, S., Wu, H., & Zhang, Y. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00591 · Cited by 207
Khan, S. R. (2012) · Urological Research · doi:10.1007/s00240-011-0448-9 · Cited by 198
“mice models [193, 194] which showed amelioration of diseases including hypertension, atherosclerosis, restenosis”
BackgroundNADPH Oxidases in Heart Failure: Poachers or Gamekeepers?
Zhang, M., Perino, A., Ghigo, A., Hirsch, E., & Shah, A. M. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4550 · Cited by 196
“A diverse range of compounds are potential Nox inhibitors and these have been comprehensively reviewed recently (49, 99).”
BackgroundOxidative stress, Noxs, and hypertension: Experimental evidence and clinical controversies
Montezano, A. C., & Touyz, R. M. (2012) · Annals of Medicine · doi:10.3109/07853890.2011.653393 · Cited by 193
“Such therapies could have potential in the management of redox-sensitive diseases associated with cardiovascular and renal damage, including hypertension (46,165).”
BackgroundInfluentialHydrogen Peroxide Promotes Aging-Related Platelet Hyperactivation and Thrombosis
Dayal, S., Wilson, K. M., Motto, D. G., Miller, F. J., Chauhan, A. K., & Lentz, S. R. (2013) · Circulation · doi:10.1161/circulationaha.112.000966 · Cited by 192
“and peptide-based inhibitors of Nox2-containing NADPH oxidases subunits are currently in development.(49,50)”
BackgroundOxidative stress and reactive oxygen species: a review of their role in ocular disease
Ung, L., Pattamatta, U., Carnt, N., Wilkinson-Berka, J. L., Liew, G., & White, A. J. R. (2017) · Clinical Science · doi:10.1042/cs20171246 · Cited by 192
COPD and stroke: are systemic inflammation and oxidative stress the missing links?
Austin, V., Crack, P. J., Bozinovski, S., Miller, A. A., & Vlahos, R. (2016) · Clinical Science · doi:10.1042/cs20160043 · Cited by 190
Oxidative Stress and Antioxidant Treatments in Cardiovascular Diseases
Wang, W., & Kang, P. M. (2020) · Antioxidants · doi:10.3390/antiox9121292 · Cited by 188
Peroxiredoxin 6 in the repair of peroxidized cell membranes and cell signaling
Fisher, A. B. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.12.003 · Cited by 189
“cell injury in a variety of diseases [161] .”
Crystal structures and atomic model of NADPH oxidase
Magnani, F., Nenci, S., Millana Fananas, E., Ceccon, M., Romero, E., Fraaije, M. W., & Mattevi, A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702293114 · Cited by 185
NADPH Oxidases: From Molecular Mechanisms to Current Inhibitors
Cipriano, A., Viviano, M., Feoli, A., Milite, C., Sarno, G., Castellano, S., & Sbardella, G. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00770 · Cited by 177
Antioxidant Strategies in the Management of Diabetic Neuropathy
Oyenihi, A. B., Ayeleso, A. O., Mukwevho, E., & Masola, B. (2015) · BioMed Research International · doi:10.1155/2015/515042 · Cited by 185
Gorin, Y., Cavaglieri, R. C., Khazim, K., Lee, D.-Y., Bruno, F., Thakur, S., Fanti, P., Szyndralewiez, C., Barnes, J. L., Block, K., et al. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00396.2014 · Cited by 183
“This is particularly relevant since treatment with antioxidants, such as vitamins E and C, failed to ameliorate the complications related to cardiovascular disease or diabetes (11, 12, 14, 38).”
BackgroundThe NADPH oxidase Nox4 has anti-atherosclerotic functions
Schürmann, C., Rezende, F., Kruse, C., Yasar, Y., Löwe, O., Fork, C., van de Sluis, B., Bremer, R., Weissmann, N., Shah, A. M., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv460 · Cited by 177
“As a consequence, a concept emerged that rather than scavenging ROS, blocking their enzymatic production might be a better way to prevent vascular oxidative stress.(3)”
BackgroundCarvalho, C., & Moreira, P. I. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00806 · Cited by 177
Hyperglycemia and Endothelial Dysfunction in Atherosclerosis: Lessons from Type 1 Diabetes
Funk, S. D., Yurdagul, A., & Orr, A. W. (2012) · International Journal of Vascular Medicine · doi:10.1155/2012/569654 · Cited by 176
“Although many antioxidant therapies targeting multiple sources of ROS in experimental models have shown promise, several clinical trials utilizing antioxidants appear to confer no significant protection [73, 135].”
BackgroundInvertebrate extracellular phagocyte traps show that chromatin is an ancient defence weapon
Robb, C. T., Dyrynda, E. A., Gray, R. D., Rossi, A. G., & Smith, V. J. (2014) · Nature Communications · doi:10.1038/ncomms5627 · Cited by 172
“DPI inhibits flavoprotein oxidoreductases (including nicotinamide adenine dinucleotide phosphate (NADPH) oxidase) while apocynin inhibits the assembly of NADPH oxidase 27 .”
Oberkampf, M., Guillerey, C., Mouriès, J., Rosenbaum, P., Fayolle, C., Bobard, A., Savina, A., Ogier-Denis, E., Enninga, J., Amigorena, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04686-8 · Cited by 171
Liu, Y., Guo, J.-Z., Liu, Y., Wang, K., Ding, W., Wang, H., Liu, X., Zhou, S., Lu, X.-C., Yang, H.-B., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06841-7 · Cited by 165
Novel aspects of ROS signalling in heart failure
Hafstad, A. D., Nabeebaccus, A. A., & Shah, A. M. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-013-0359-8 · Cited by 165
“, by NOX proteins) provides the opportunity to develop newer and more targeted approaches [23].”
Anti-hypertensive Herbs and their Mechanisms of Action: Part I
Al Disi, S. S., Anwar, M. A., & Eid, A. H. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00323 · Cited by 163
“Within seconds of its production , NO reacts with superoxide anions ( Drummond et al .”
BackgroundThe Role of Oxidative Stress in Cardiovascular Aging and Cardiovascular Diseases
Izzo, C., Vitillo, P., Di Pietro, P., Visco, V., Strianese, A., Virtuoso, N., Ciccarelli, M., Galasso, G., Carrizzo, A., & Vecchione, C. (2021) · Life · doi:10.3390/life11010060 · Cited by 162
Martínez-Revelles, S., Avendaño, M. S., García-Redondo, A. B., Álvarez, Y., Aguado, A., Pérez-Girón, J. V., García-Redondo, L., Esteban, V., Redondo, J. M., Alonso, M. J., et al. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4335 · Cited by 158
“It is well known that hypertension is associated with increased vascular ROS production from NAD(P)H Oxidase, among other sources, and/or with altered antioxidant defenses (8, 12).”
InfluentialZhang, H., Chen, X., Zong, B., Yuan, H., Wang, Z., Wei, Y., Wang, X., Liu, G., Zhang, J., Li, S., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13743 · Cited by 171
“Moreover, many studies have indicated that mitochondrial damage and oxidative stress are important risk factors for DCM and that mitochondrial ROS is a pivotal link between oxidative stress and NLRP3 inflammasome activation.(44,45) Recently, a study has shown that monocytes and/or MDMs from T2D or DCM patients stimula…”
BackgroundNADPH—The Forgotten Reducing Equivalent
Chandel, N. S. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a040550 · Cited by 180
Roque, F. R., Briones, A. M., García‐Redondo, A. B., Galán, M., Martínez‐Revelles, S., Avendaño, M. S., Cachofeiro, V., Fernandes, T., Vassallo, D. V., Oliveira, E. M., et al. (2013) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02224.x · Cited by 155
“Reactive oxygen species (ROS) seem to play a major role in these alterations through their effects on cellular function such as inactivation of NO, regulation of cell growth and differentiation, modulation of synthesis and degradation of extracellular matrix (ECM) proteins and activation of many kinases and of pro-inf…”
BackgroundEndosomal nox2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy
To, E. E., Vlahos, R., Luong, R., Halls, M. L., Reading, P. C., King, P. T., Chan, C., Drummond, G. R., Sobey, C. G., Broughton, B. R. S., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00057-x · Cited by 154
Self-citationOxidative Stress and Antioxidants in Atherosclerosis Development and Treatment
Poznyak, A. V., Grechko, A. V., Orekhova, V. A., Chegodaev, Y. S., Wu, W., & Orekhov, A. N. (2020) · Biology · doi:10.3390/biology9030060 · Cited by 201
“NADH oxidases consist of two membrane-bound subunits, p22phox and a Nox homologue, and several cytosolic regulatory subunits [29].”
BackgroundRegulation of NADPH oxidases in skeletal muscle
Ferreira, L. F., & Laitano, O. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.05.011 · Cited by 151
Role of Nox4 in murine models of kidney disease
Bábelová, A., Avaniadi, D., Jung, O., Fork, C., Beckmann, J., Kosowski, J., Weißmann, N., Anilkumar, N. P., Shah, A. M., Schaefer, L., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.06.027 · Cited by 157
NADPH oxidases: key modulators in aging and age-related cardiovascular diseases?
Sahoo, S., Meijles, D. N., & Pagano, P. J. (2016) · Clinical Science · doi:10.1042/cs20150087 · Cited by 146
“Novel approaches and rational drug design strategies have yielded isoform selectivity for Nox2 and been discussed in greater detail [107,108,247,258,266].”
BackgroundSuppressing production of reactive oxygen species (ROS) for influenza A virus therapy
Vlahos, R., Stambas, J., & Selemidis, S. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.09.001 · Cited by 155
Self-citation
Metadata
- Authors
- Drummond, G. R., Selemidis, S., Griendling, K. K., & Sobey, C. G.
- Affiliations
- Monash University (AU)
- Emory University (US)
- Corresponding author
- Drummond, Grant R.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2011-06
- Volume
- 10
- Issue
- 6
- Pages
- 453-471
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC3361719
- OpenAlex
- W1974997758
- Cited by
- 899
- References
- 237
- Citations by year
- 2026: 25 · 2025: 25 · 2024: 38 · 2023: 35 · 2022: 51 · 2021: 66 · 2020: 69 · 2019: 55 · 2018: 63 · 2017: 77 · 2016: 69 · 2015: 71 · 2014: 83 · 2013: 88 · 2012: 71
- FWCI
- 8.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RMIT Research Repository (RMIT University Library) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- National Heart, Lung, and Blood Institute (HL38206, R01HL038206, HL095070, HL058863, R37HL038206, HL-092120, R01HL092120, P01HL095070, R01HL058863)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- NADPH oxidase, NOX1, NOX2, oxidative stress, reactive oxygen species, NADPH oxidase inhibitors, p47phox, endothelial dysfunction, vascular inflammation, atherogenesis, arterial remodeling, hypertension, hypercholesterolemia, diabetes mellitus, aging, cardiovascular disease
- MeSH terms
- NADPH Oxidase 1, NADPH Oxidase 2, Animals, Antioxidants, Humans, Membrane Glycoproteins, NADH, NADPH Oxidoreductases, Vascular Diseases, Drug Delivery Systems, Reactive Oxygen Species, Oxidative Stress, NADPH Oxidases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.